5-Amino-4-oxopentanoic acid photodynamic diagnosis guided microsurgery and photodynamic therapy on VX2 brain tumour implanted in a rabbit model

Chinese Medical Journal

Volumn 122, Issue 11, 2009, Pages 1316-1321

  Xiao, Hong ^a   Liao, Qiong ^b   Cheng, Ming ^c   Li, Fei ^a   Xie, Bing ^a   Li, Mei ^a   Feng, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

5 Amino 4 oxopentanoic acid; Mean survival time; Photodynamic diagnosis; Photodynamic therapy; VX2 tumour model

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER GRAFT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; HISTOPATHOLOGY; MICROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PHOTODYNAMICALLY GUIDED MICROSURGERY; RABBIT; SURVIVAL TIME; WHITE LIGHT MICROSURGERY;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MICROSURGERY; PHOTOCHEMOTHERAPY; RABBITS; RANDOM ALLOCATION;

EID: 68249160644     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.11.015     Document Type: Article

References (22)

1. Eljamel S. New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors. Technol Cancer Res Treat 2003; 2: 303-309.
2. Li F, Feng H, Lin JK, Zhu G, Chen Z, Li CY. Photodynamic therapy on implanted VX2 tumor in rabbit brains. Prog Biomed Opt Imaging 2005; 5967: 37-40.
3. Freeberg JA, Serachitopol DM, McKinnon N, Price R, Atkinson EN, Cox DD, et al. Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe. J Biomed Opt 2007; 12: 340-345.
4. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006; 7: 392-401.
5. Li F, Feng H, Lin JK, Meng H, Wu N. Establishment of a rabbit model of brain tumor by VX2 tumor implantation. Acta Lab Anim Sci Sin 2006; 14: 193-196.
6. Lilge L, Olivo MC, Schatz SW, MaGuire JA, Patterson MS, Wilson BC. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. Br J Cancer 1996; 73: 332-343.
7. Stummer W, Stepp H, Moller G, Ehrhardt A, Leonhard M, Reulen HJ. Technical principles for protoporphyrin-IX fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurchir 1998; 140: 995-1000.
8. Shapiro WR. Current therapy for brain tumors: back to the future. Arch Neurol 1999; 56: 429-432.
9. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996; 39: 235-250.
10. Lilge L, Portnoy M, Wilson BC. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br J Cancer 2000; 83: 1110-1117.
11. Rodriguez L, Batlle A, Venosa G, Battah S, Dobbin P, Macrobert AJ, et al. Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br J Pharmacol 2006; 147: 825-833.
12. Li M, Feng H, Li F, Wang XR, Wu N, Chen Z, et al. The experimerntal study of exterior and interior photosensitizer PDT on implanted C6 Glioma in rat brain. Chin J Minimally Invasive Neurosurgery (Chin) 2006; 11: s26.
13. Li M, Li F, Lu JY, Feng H. Effect of HpD-PDT on cultured rat C6 glioma cells. J Int Neurol Neurosurg 2008; 38: 12-17.
14. Li F, Zhu G, Lin JK, Meng H, Wu N, Feng H, et al. Photodynamic therapy increases brain edema and intracranial pressure in a rabbit brain tumor model. Acta Neurochir 2006; 96: s422-s425.
15. Muller PJ, Wilson BC. Photodynamic therapy for recurrent supratentorial gliomas. Semin Surg Oncol 1995; 11: 346-354.
16. Ennis SR, Novotny A, Xiang J, Shakui P, Masada T, Stummer W, et al. Transport of 5-aminolevulinic acid between blood and brain. Brain Res 2003; 959: 226-234.
17. Friesen SA, Hjortland GO, Madsen SJ, Hirschberg H, Engebraten O, Nesland JM, et al. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). Int J Oncol 2002; 21: 577-582.
18. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000; 93: 1003-1013.
19. Zhao SG, Teng L, Li Y, Ju DH, Zhang YB,Yang KB, et al. Fluorescence-guided microsurgical resection of human glioma with using 5-aminolevulinic acid. Chin J Neurosurg (Chin) 2007; 5: 369-372.
20. Brunner H, Hausmann F, Knuechel R. New 5-aminolevulinic acid esters - efficient protoporphyrin precursors for photodetection and photodynamic therapy. Photochem Photobiol 2003; 78: 481-486.
21. Stylli SS, Howes M, MacGregor L, Rajendra P, Kaye AH. Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci 2004; 11: 584-496.
22. Fritsch C, Ruzicka T. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol 2006; 25: 425-439.